TCL Archive NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz. March 12, 2004
TCL Archive First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target April 24, 2009
TCL Archive Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors September 30, 1977
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
